Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Serhan

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Prostaglandins|February 1, 1997
Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?C N Serhan
Methods in Enzymology|January 1, 1990
High-performance liquid chromatography separation and determination of lipoxinsC N Serhan
Archivum Immunologiae Et Therapiae Experimentalis|August 2, 2001
Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory sideC N Serhan
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
On the generation of lipoxins and novel related compounds by human neutrophils: relationship to leukotriene productionC N Serhan
Free Radical Research Communications|January 1, 1989
Human red cells enhance the formation of 5-lipoxygenase-derived products by neutrophilsA Stern, C N Serhan
Biochemistry|September 8, 1992
Lipoxin generation by permeabilized human plateletsM Romano, C N Serhan
Biochemistry|December 26, 1995
Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interactionS Fiore, C N Serhan
Journal of Periodontal Research|February 24, 2000
Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseasesM Pouliot, C N Serhan
The Journal of Clinical Investigation|June 20, 2001
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathwaysC N Serhan, E Oliw
British Journal of Pharmacology|October 30, 2007
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genusC N Serhan, N Chiang
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Prostaglandins|February 1, 1997
Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?C N Serhan
Methods in Enzymology|January 1, 1990
High-performance liquid chromatography separation and determination of lipoxinsC N Serhan
Archivum Immunologiae Et Therapiae Experimentalis|August 2, 2001
Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory sideC N Serhan
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1989
On the generation of lipoxins and novel related compounds by human neutrophils: relationship to leukotriene productionC N Serhan
Free Radical Research Communications|January 1, 1989
Human red cells enhance the formation of 5-lipoxygenase-derived products by neutrophilsA Stern, C N Serhan
Biochemistry|September 8, 1992
Lipoxin generation by permeabilized human plateletsM Romano, C N Serhan
Biochemistry|December 26, 1995
Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interactionS Fiore, C N Serhan
Journal of Periodontal Research|February 24, 2000
Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseasesM Pouliot, C N Serhan
The Journal of Clinical Investigation|June 20, 2001
Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathwaysC N Serhan, E Oliw
British Journal of Pharmacology|October 30, 2007
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genusC N Serhan, N Chiang
Pageof 19